Shanghai RAAS Blood Products Co Ltd Class A (002252) — Cash Flow Quality Index
Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Cash Flow Quality Index of -7.94x as of December 2025. Operating cash flow of CN¥-843.75 Million is below net income of CN¥106.27 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 002252 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai RAAS Blood Products Co Ltd Class A Cash Flow Quality Index (2005–2025)
Historical Cash Flow Quality Index for Shanghai RAAS Blood Products Co Ltd Class A across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Shanghai RAAS Blood Products Co Ltd Clas to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)
Year-by-year earnings quality comparison for Shanghai RAAS Blood Products Co Ltd Class A. For live market cap and the full company financial profile, see market value of Shanghai RAAS Blood Products Co Ltd Clas.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | CN¥-104.89 Million | CN¥1.58 Billion | ▲ +69.7% |
| 2024 | -0.22x | CN¥-482.06 Million | CN¥2.19 Billion | ▼ -117.2% |
| 2023 | 1.28x | CN¥2.28 Billion | CN¥1.78 Billion | ▲ +38.9% |
| 2022 | 0.92x | CN¥1.73 Billion | CN¥1.87 Billion | ▼ -8.2% |
| 2021 | 1.00x | CN¥1.29 Billion | CN¥1.29 Billion | ▲ +13.3% |
| 2020 | 0.89x | CN¥1.17 Billion | CN¥1.32 Billion | ▼ -38.5% |
| 2019 | 1.44x | CN¥872.69 Million | CN¥605.92 Million | ▲ +345.8% |
| 2017 | 0.32x | CN¥268.76 Million | CN¥831.95 Million | ▼ -18.3% |
| 2016 | 0.40x | CN¥638.22 Million | CN¥1.61 Billion | ▼ -23.2% |
| 2015 | 0.52x | CN¥762.42 Million | CN¥1.48 Billion | ▼ -43.6% |
| 2014 | 0.91x | CN¥465.96 Million | CN¥510.51 Million | ▲ +244.4% |
| 2013 | -0.63x | CN¥-90.11 Million | CN¥142.52 Million | ▼ -153.7% |
| 2012 | 1.18x | CN¥263.46 Million | CN¥223.89 Million | ▲ +31.8% |
| 2011 | 0.89x | CN¥178.03 Million | CN¥199.45 Million | ▼ -17.3% |
| 2010 | 1.08x | CN¥200.21 Million | CN¥185.40 Million | ▲ +27.3% |
| 2009 | 0.85x | CN¥116.01 Million | CN¥136.77 Million | ▼ -17.1% |
| 2008 | 1.02x | CN¥107.64 Million | CN¥105.18 Million | ▼ -52.5% |
| 2007 | 2.15x | CN¥175.71 Million | CN¥81.63 Million | ▲ +103.7% |
| 2006 | 1.06x | CN¥53.58 Million | CN¥50.71 Million | ▲ +0.2% |
| 2005 | 1.05x | CN¥54.02 Million | CN¥51.24 Million | — |